mesenchymal stem cells - Cleveland Clinic

Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}}
Now: 1770481340988
Cache Key: cqdTagPageBySlug:mesenchymal-stem-cells
fetchCache[cqdTagPageBySlug:mesenchymal-stem-cells].expirationTime: falsey
fetchCache[cqdTagPageBySlug:mesenchymal-stem-cells]. seconds remaining: falsey
All fetchCache expiration times:
-- Key: cqdNotFoundPage, seconds remaining: 3980
-- Key: cqdTagPageBySlug:transcatheter-valve-repair, seconds remaining: -6523
-- Key: cqdPostsByTag:cqd-migrated-tag-26975,1,10, seconds remaining: -6455
-- Key: cqdTagPageBySlug:pancreaticoduodenectomy, seconds remaining: -6123
-- Key: cqdPostsByTag:cqd-migrated-tag-6075,1,10, seconds remaining: -6051
-- Key: cqdTagPageBySlug:saphenous-vein-graft, seconds remaining: -5575
-- Key: cqdPostsByTag:cqd-migrated-tag-19102,1,10, seconds remaining: -5503
-- Key: cqdTagPageBySlug:major-cardiac-adverse-event-mace, seconds remaining: -5241
-- Key: cqdPostsByTag:cqd-migrated-tag-23274,1,10, seconds remaining: -5169
-- Key: cqdTagPageBySlug:nursing-research, seconds remaining: 2868
-- Key: cqdPostsByTag:cqd-migrated-tag-692,1,10, seconds remaining: 2940
-- Key: cqdTagPageBySlug:cerebrovascular-injury, seconds remaining: 3594
-- Key: cqdPostsByTag:cqd-migrated-tag-24481,1,10, seconds remaining: 3676
-- Key: cqdTagPageBySlug:transgender-health, seconds remaining: 3980
-- Key: cqdPostsByTag:cqd-migrated-tag-3410,1,10, seconds remaining: 4060
-- Key: cqdTagPageBySlug:bladder-cancer, seconds remaining: 4329
-- Key: cqdPostsByTag:cqd-migrated-tag-843,3,10, seconds remaining: 4407
-- Key: cqdTagPageBySlug:patient-access, seconds remaining: 8627
-- Key: cqdPostsByTag:cqd-migrated-tag-1554,1,10, seconds remaining: 8695
conditions:
-- false,
-- NA,
-- NA,
-- NA
-- false
Cache miss for key cqdTagPageBySlug:mesenchymal-stem-cells - retrieving from Sanity
CCCache.dataFetchCount: 10595
Cache cleanup seconds remaining: 22868

Tag: mesenchymal stem cells

Phase 2 Trial Hints at Promise of Cellular Therapy for Progressive MS

Intrathecally Delivered Enhanced Stem Cells Show Promise in Progressive MS